Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aerovate Therapeutics
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
PAH belonging to one of the subgroups:
1. I/HPAH, PAH-CTD,
2. PAH due to drugs and/or toxins/chemicals (having been in the care of the investigator for at least one year with no relapses of drug or toxin/chemical abuse),
3. HIV associated or
4. PAH due to repaired congenital heart disease (at least 1 year since repair)
World Health Organization (WHO) Functional Class II, III or IV symptoms
Stable concomitant background therapy of at least one PAH approved medications
Able to walk a distance of at least 100 m but no more than 475 m during the Screening 6-minute walk tests.
You may not be if
Pulmonary hypertension (PH) belonging to Groups 2 to 5
